Dizal Pharmaceutical Co Ltd
SSE:688192
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Dizal Pharmaceutical Co Ltd
SSE:688192
|
CN |
|
P
|
Packaging Corp of America
XMUN:PKA
|
US |
|
T
|
Tinybuild Inc
LSE:TBLD
|
US |
|
V
|
Volkswagen AG
XMUN:VOW
|
DE |
|
California Water Service Group
NYSE:CWT
|
US |
|
F
|
Fuji Electric Co Ltd
OTC:FELTY
|
JP |
|
R
|
Renault SA
F:RNL1
|
FR |
|
Doubleverify Holdings Inc
NYSE:DV
|
US |
|
Menon Bearings Ltd
BSE:523828
|
IN |
|
G
|
Gen Digital Inc
F:SYM
|
US |
|
E
|
Eastgroup Properties Inc
F:EGO
|
US |
|
P
|
Pennant Group Inc
NASDAQ:PNTG
|
US |
|
L
|
Land and Houses PCL
SET:LH
|
TH |
|
Origin Energy Ltd
F:ORL0
|
AU |
|
Fesh Fash Snack Food Production Co
SAU:9515
|
SA |
|
Z
|
Zimmer Biomet Holdings, Inc
F:ZIM
|
US |
|
Zespol Elektrocieplowni Wroclawskich Kogeneracja SA
F:2ZO
|
PL |
|
Jiayuan International Group Ltd
HKEX:2768
|
HK |
|
M
|
Mondi PLC
JSE:MNP
|
UK |
|
C
|
Compagnie Financiere Richemont SA
DUS:RIT1
|
CH |
Bankruptcy Probability
Dizal Pharmaceutical Co Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Dizal Pharmaceutical Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CN |
D
|
Dizal Pharmaceutical Co Ltd
SSE:688192
|
31.4B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
509.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
249B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
208B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
137.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
96.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
96.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
51B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
52.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
38.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Dizal Pharmaceutical Co Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Dizal Pharmaceutical Co Ltd has total debt of 973.5m CNY. This includes both short-term (48.9m CNY) and long-term (924.6m CNY) debt.
You can find a full breakdown on its Balance Sheet.